AtriCure, Inc
Price
FilingsNewest: 10-Q, Quarterly reportJul 27 →InsidersNo open-market buys. 5 insiders sold $1.1M, 0 of 7 sales on a 10b5-1 plan.→HoldersBlackRock 8.8%Wellington Management Group LLP 6.9%Vanguard Portfolio 6.1%→PeersClosest companies: OBIO, PROF, NRXS→
From the filings
Figures
- Revenue
- $569.6Mlast 12 months
- Net income
- $10.6Mlast 12 months
- Operating cash flow
- $64.4Mlast 12 months
- Cash and equivalents
- $167.8Mat the last balance sheet
- Total debt
- $61.0Mat the last balance sheet
- Shares outstanding
- 50.9M shareson issue